• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Industrials·300408.SZ
Share

Chaozhou Three-Circle Stocks

CN¥ 86.14Last Updated 23.10.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 27.86B

CN¥ 86.14
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Chaozhou Three-Circle (Group) Co., Ltd. is a global enterprise dedicated to the research, development, production, and sales of essential electronic materials, advanced electronic components, and cutting-edge communication devices. The company's diverse product portfolio includes ceramic components for modern mobile phones (such as exterior parts and fingerprint module covers) and smart wearable technologies, alongside fundamental electronic parts like lead resistors and multilayer ceramic chip capacitors. For optical communication applications, they manufacture ceramic ferrules, sleeves, rapid fiber optic connectors, MT ferrules, and ceramic guide pins. Additionally, their offerings extend to various packaging solutions, including glass and metal encapsulation, ceramic packaging bases, ceramic wedges, and capillaries. They also provide sophisticated items like piezo micro dispensing valve systems, various substrates (alumina, aluminum nitride), electronic and solder pastes, nano-zirconia powder, metallized ceramics, and ceramic structural parts. These innovative products are vital for numerous sectors, including optical communications, general electronics, electrical engineering, industrial machinery, energy efficiency, environmental conservation, renewable energy, biotechnology, and fashion. Established in 1970, the company is headquartered in Chaozhou, China.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of 300408.SZ is 134 and suggests 42.1% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.10.2026 16:01

Highlights in Small-Cap Stocks: The Merck Deal, the Success of a Hair Loss Pill, and Braze's "Wow Factor"

24.10.2026 13:01

AI investors are already on the brink, a “French kiss” for the euro, and hackers at the gates

24.10.2026 05:04

Hedge funds have ramped up their bets against the euro to a 2020 high

24.10.2026 04:46

France Avoided a Downgrade by Moody’s After a Week of Crisis

24.10.2026 04:37

A key Novartis drug failed to meet expectations. The stock price fell

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026